0001179110-14-014708.txt : 20141001
0001179110-14-014708.hdr.sgml : 20141001
20141001164336
ACCESSION NUMBER: 0001179110-14-014708
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140929
FILED AS OF DATE: 20141001
DATE AS OF CHANGE: 20141001
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HEALTH NET INC
CENTRAL INDEX KEY: 0000916085
STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324]
IRS NUMBER: 954288333
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21650 OXNARD ST
CITY: WOODLAND HILLS
STATE: CA
ZIP: 91367
BUSINESS PHONE: 8186766000
MAIL ADDRESS:
STREET 1: 225 N MAIN ST
CITY: PUEBLO
STATE: CO
ZIP: 81003
FORMER COMPANY:
FORMER CONFORMED NAME: FOUNDATION HEALTH SYSTEMS INC
DATE OF NAME CHANGE: 19970513
FORMER COMPANY:
FORMER CONFORMED NAME: HEALTH SYSTEMS INTERNATIONAL INC
DATE OF NAME CHANGE: 19940207
FORMER COMPANY:
FORMER CONFORMED NAME: HN MANAGEMENT HOLDINGS INC/DE/
DATE OF NAME CHANGE: 19931213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ESCARRA VICKI B
CENTRAL INDEX KEY: 0001197666
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12718
FILM NUMBER: 141133630
MAIL ADDRESS:
STREET 1: AMERICA'S SECOND HARVEST
STREET 2: 35 EAST WACKER DR., SUITE 2000
CITY: CHICAGO
STATE: IL
ZIP: 60601
4
1
edgar.xml
FORM 4 -
X0306
4
2014-09-29
0
0000916085
HEALTH NET INC
HNT
0001197666
ESCARRA VICKI B
C/O HEALTH NET, INC.
21650 OXNARD STREET
WOODLAND HILLS
CA
91367
1
0
0
0
Common Stock
2014-09-29
4
S
0
4468
45.69
D
17852
D
Common Stock
2014-09-29
4
M
0
11600
28.08
A
29452
D
Common Stock
2014-09-29
4
S
0
9500
46.46
D
19952
D
Common Stock
2014-09-29
4
S
0
2100
46.69
D
17852
D
Common Stock
2014-09-29
4
M
0
7366
15.3
A
25218
D
Common Stock
2014-09-29
4
S
0
6266
46.47
D
18952
D
Common Stock
2014-09-29
4
S
0
1100
46.70
D
17852
D
Common Stock
2014-09-29
4
M
0
12859
23.51
A
30711
D
Common Stock
2014-09-29
4
S
0
8928
46.43
D
21783
D
Common Stock
2014-09-29
4
S
0
3931
46.65
D
17852
D
Stock Option (Right to Buy)
28.08
2014-09-29
4
M
0
11600
0
D
2018-05-09
Common Stock
11600
0
D
Stock Option (Right to Buy)
15.3
2014-09-29
4
M
0
7366
0
D
2016-05-22
Common Stock
7366
0
D
Stock Option (Right to Buy)
23.51
2014-09-29
4
M
0
12859
0
D
2017-05-13
Common Stock
12859
0
D
The sale of Common Stock by the Reporting Person, as reported on this Form 4, was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 (the "Act"), as amended.
Exercise of a Stock Option (Right to Buy) granted to the Reporting Person on May 9, 2008 under the Issuer's 2006 Long-Term Incentive Plan, as amended (the "2008 Grant"), in a transaction exempt under Rule 16b-3 of the Act. The exercise of the 2008 Grant was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.64 to $46.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.64 to $46.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
Exercise of a Stock Option (Right to Buy) granted to the Reporting Person on May 22, 2009 under the Issuer's 2006 Long-Term Incentive Plan, as amended (the "2009 Grant"), in a transaction exempt under Rule 16b-3 of the Act. The exercise of the 2009 Grant was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.66 to $46.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.67 to $46.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
Exercise of a Stock Option (Right to Buy) granted to the Reporting Person on May 13, 2010 under the Issuer's 2006 Long-Term Incentive Plan, as amended (the "2010 Grant"), in a transaction exempt under Rule 16b-3 of the Act. The exercise of the 2010 Grant was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.58 to $46.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.58 to $46.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
The 2008 Grant became exercisable in 33 1/3% increments on each of the first, second, and third anniversaries of May 9, 2008, the grant date.
The 2009 Grant became exercisable in 33 1/3% increments on each of the first, second, and third anniversaries of May 22, 2009, the grant date.
The 2010 Grant became exercisable in 33 1/3% increments on each of the first, second, and third anniversaries of May 13, 2010, the grant date.
/s/ Vicki Escarra
2014-10-01